1. Hematopoietic Cell Transplantation with and without Sorafenib Maintenance for Patients with FLT3-ITD Acute Myeloid Leukemia in CR1 
Andrew M. Brunner, MD, Shuli Li, Amir T. Fathi, MD, Vincent T. Ho, MD, Richard M. Stone, MD, Robert J. Soiffer, MD, Yi-Bin Chen, MD 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, Pages S198-S199 (March 2016)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Disease-free and Overall Survival for FLT3-ITD AML patients, with or without sorafenib maintenance after HCT. Landmark analysis was performed from median date of sorafenib initiation (d+68).
Biology of Blood and Marrow Transplantation  , S198-S199DOI: ( /j.bbmt )
Copyright © Terms and Conditions